The Global Disposable Medical Sensors Market was valued at $4,823 million in 2016, and is expected to reach at $9,700 million by 2023, registering a CAGR of 10.2% from 2017 to 2023. Disposable medical sensors are used in healthcare sector as pressure detectors, temperature sensors, image sensors, and others. These sensors aid in accurate monitoring, treatment, and diagnosis of a disease. Furthermore, they sensors play a significant role in making a medical device more safe and effective, while simplifying their operation.
The advent of disposable sensors and biosensors has played a vital role in the evolution of sensors in healthcare. Hence, the disposable medical sensors are a preferred option among patients and healthcare professionals for easy detection of diseases. In this regard, many key players develop and commercialize novel sensors. For instance, in September 2016, Abbott received approval for its FreeStyle Libre Pro system, a continuous glucose monitoring (CGM) system.
The global disposable medical sensors market is segmented based on product type, placement type, application, and end user. Based on product type the market is segmented into biosensor, temperature sensor, pressure sensor, humidity sensor, force sensor, image sensor, and others. By placement type, the market is divided into wearable sensors, invasive sensors, implantable sensors, ingestible sensors, and strip sensors. Based on application, the market is categorized into patient monitoring, diagnostics, and therapeutics.
Patient monitoring is further segmented into continuous blood pressure monitoring, implantable loop recorder, cardiac monitoring electrode, pulse oximeters, smart pills, continuous blood glucose monitoring (CGM), and others. Diagnostics application is further classified to capsule endoscopes, HIV test strip sensors, pregnancy test strip sensors, drug and alcohol test strip sensors, and blood glucose test strip sensors. The therapeutics application is segmented into insulin pump sensors, cardiac therapeutic electrode sensors, and cardiac catheter sensors. Based on end user, the market is divided into hospitals, clinics, diagnostic laboratories, and home care. Among product type, biosensor segment occupied dominant share of three sevenths of the total market in 2016, and is expected maintain this trend during the forecast period, owing to its high adoption globally. In the placement type segment, the ingestible sensor is expected to grow with highest CAGR of 11.0% during the forecast period.
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research